The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 1.

Table. 1.

Occurrence of the non-discriminated reactive results (NDR) in NAT and serologically reactive results of HCV or HIV in donors with NDR (2012. 6∼2018. 10)

PeriodNo. of donationsNo. of NDRNo. of anti-HCV reactiveNo. of anti-HIV reactive
2012. 6∼2012. 121,397,511725 (0.05%)2 (0.28%)1 (0.14%)
2013. 1∼2013. 122,708,2231,515 (0.06%)0 (0.00%)5 (0.33%)
2014. 1∼2014. 122,844,5691,294 (0.05%)4 (0.31%)2 (0.15%)
2015. 1∼2015. 122,872,2001,583 (0.06%)1 (0.06%)2 (0.13%)
2016. 1∼2016. 122,645,2081,387 (0.05%)2 (0.14%)1 (0.07%)
2017. 1∼2017. 122,714,8581,495 (0.06%)4 (0.27%)6 (0.40%)
2018. 1∼2018. 102,215,8921,021 (0.05%)4 (0.39%)1 (0.10%)
Total17,398,4619,020 (0.05%)17 (0.19%)18 (0.20%)

Abbreviations: NDR, non-discriminated reactive result; NAT, nucleic acid amplification test.

Korean J Blood Transfus 2019;30:163-7 https://doi.org/10.17945/kjbt.2019.30.2.163
© 2019 Korean J Blood Transfus